Skip to content


Key Takeaways for the Medical Writer from FDA’s Public Meeting: Supporting the Future of Rare Disease Product Development

By Jeanette Towles / February 24, 2020 /

FDA’s public meeting on February 24th left no uncertainty as to the future direction of drug development in rare diseases: 1) patient-centric approaches that incorporate patient and caregiver input at all levels to ensure that clinical trial endpoints are robust and meaningful; and 2) utilization of patient data (registries, cases, natural history, and real world…

Read More

Defining ‘Medical Writer’ in a Job Description When the Role Defies Definition

By Jeanette Towles / February 10, 2020 /

Have you ever noticed in looking at job descriptions for medical writers that, regardless of the size of the hiring company, you end up with an array of interpretations of the role? Here are some examples: • MW may/may not write briefing books, write or review the label, or assist in regulatory responses • MW…

Read More